After investigating the effects of the inhibitor on CLL viability, we found that macitentan slightly favoured spontaneous apoptosis and affected ET-1 mediated survival advantage of CLL cells (Figure 2A). Here, EDN1 is linked to B-cell chronic lymphocytic leukemia.